PhysCade
About PhysCade
PhysCade is a healthcare AI company that has developed a specialized AI-driven software and hardware platform. This system is designed to analyze and visualize intra-cardiac electrophysiological data collected during heart rhythm studies.
The PhysCade System assists clinicians by providing detailed maps that identify early activation sites and other features of interest within the heart during arrhythmia procedures. This technology aims to empower physicians with more informed clinical decisions during electrophysiology procedures, ultimately improving patient care for individuals with heart rhythm disorders.
The system is intended for the analysis, display, and storage of cardiac electrophysiological data and maps for physician review. It functions as an AI-enabled diagnostic tool that post-processes electrograms from compatible multi-electrode cardiac catheters during mapping procedures, delivering outputs such as earliest activation sites, activation times, voltage, and signal quality via proprietary software on a computer workstation.
Focus Areas
Business Intelligence
| Key Investors | HHS, Lotus Capital Ventures, Red Bridge Ventures, Zelda Ventures |
| Partnerships | Boston Scientific (LabSystem Pro Acquisition), General Electric (MacLab CardioLab Acquisition System), Abbott (Ensite NavX/Precision System) |
| Technology | AI-driven software and hardware platform, advanced algorithms for EGM analysis, proprietary software on a computer workstation. Compatible with multi-electrode cardiac catheters and data acquisition systems including LabSystem Pro Acquisition (Boston Scientific), MacLab CardioLab Acquisition System (General Electric), and Ensite NavX/Precision System (Abbott). |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians considering PhysCade, focus on understanding how their AI-enabled diagnostic tools integrate into your existing workflow for electrogram analysis. Evaluate the clinical validation of their AI models and the transparency of their decision support outputs. Prioritize solutions that offer clear explainability for AI-driven insights, allowing you to maintain clinical oversight. Assess their interoperability with your current EMR and EP lab systems to ensure seamless data flow and minimize implementation friction. Look for robust training and ongoing support to maximize the benefits of their advanced technology.
Seamless integration with existing Electronic Medical Records (EMR) systems, Electrophysiology (EP) lab mapping systems, and PACS is crucial for PhysCade's effectiveness. Their platform should offer secure, bi-directional data exchange capabilities to pull patient data for analysis and push diagnostic insights and treatment recommendations back into the patient's record, ensuring a unified and comprehensive view of patient care.
What the Web Says
PhysCade is a company that develops a system with advanced algorithms to analyze electrograms (EGMs) for identifying regions of interest in the heart, aiming to support clinicians in making decisions related to atrial arrhythmias like atrial fibrillation. The system has undergone extensive non-clinical testing, including software/firmware and cybersecurity verification, design verification, design validation for its AI/ML system, and usability testing. The clinical significance of using the software to identify areas with spatiotemporal dispersion for catheter ablation has not been established by clinical investigations.
Overall: PositiveStrengths
- Advanced algorithms for EGM analysis
- Aids clinicians in identifying regions of interest in the heart
- Underwent rigorous software/firmware and cybersecurity testing
- Design validation confirmed AI/ML system accuracy
- Usability testing demonstrated meeting user needs
- Substantially equivalent to predicate device (Volta VX1)
Limitations
- Clinical significance for catheter ablation of atrial arrhythmias not yet established
Based on reviews from: accessdata.fda.gov
Last updated: 2026-07-19
Videos
News, demos, and interviews about PhysCade.
Videos load interactively. If none appear, search YouTube for PhysCade →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]